This Perspective covers existing patient-derived xenografts (PDXs) of prostate cancer, and their features and uses in basic and preclinical research. The authors also discuss the need for additional PDXs, and how collaboration in prostate cancer PDX research can be improved.
- Mitchell G. Lawrence
- Renea A. Taylor
- Gail P. Risbridger